A solid showing for HIV drugs sold by majority-owned ViiV Healthcare and speciality medicines like cancer therapies Zejula ...

Pfizer's quarterly earnings handily beat expectations, a boost for the company as it faces pressure from an activist investor ...

GSK is still claiming around two-thirds of the RSV vaccination share in the first nine months of the year in retail, "where ...